Welcome, this website is intended for international healthcare professionals with an interest in the treatment of Advanced Prostate Cancer. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Implementation of the AUA Castration Resistant Prostate Cancer Guidelines into Practice: Establishing a Multidisciplinary Clinic

Stratton KL, Moeller AM, Cookson MS



AUA (American Urological Association) published guidelines on the treatment of castration resistant prostate cancer in August 2013. Urologists have remained integral members of a multifaceted team of professionals treating patients with prostate cancer. We discuss approaches to implementing a guidelines based, multidisciplinary, advanced prostate cancer treatment clinic.


A supplemented PubMed® search was performed to identify published literature evaluating the treatment of castration resistant prostate cancer. Attention was placed on studies assessing a multidisciplinary approach to treating patients with castrate resistant prostate cancer. A review of currently approved agents is provided with emphasis on administration from an integrated clinic.


Treatment of patients with advanced prostate cancer remains a significant function of many urology clinics. Guidelines assist urologists with providing patients with the most appropriate care along with multispecialty collaboration. Several organizational approaches have been attempted, including all-in-one clinics, onsite clinics and virtual multidisciplinary clinics. Through close collaboration with medical oncologists, radiation oncologists and support staff patients with advanced prostate cancer can obtain the highest quality care.


Urologists remain an integral member of the multidisciplinary approach to treating castrate resistant prostate cancer. AUA guidelines for castration resistant prostate cancer are a useful tool that can be incorporated into virtual multidisciplinary clinics. Through a team approach patients receive timely and appropriate care.

Key Words: prostatic neoplasms, castration-resistant, standards, continuity of patient care, patient care team,interprofessional relations 




Register to be notified when new content is published. Only your name, country and email address needed.

Subscribe »

Latest webcast

ESMO 2016 Symposium webcast

Individualizing treatment in
metastatic prostate cancer: there
is no “one-size-fits-all” approach

EAU 2016 Scientific Programme and Sessions

View the Scientific Programme and Sessions of the 2016 EAU Annual Congress, Munich, Germany.

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.
The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views

Search this site

Search form